GS
CLB icon

Gagnon Securities’s Core Laboratories CLB Stock Holding History

Gagnon Securities’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,283
Closed -$249K – 100
2023
Q1 		$249K Buy
11,283
+16
+0.1% +$374 0.05% 92
2022
Q4 		$228K Buy
11,267
+51
+0.5% +$989 0.05% 92
2022
Q3 		$151K Buy
11,216
+42
+0.4% +$708 0.03% 95
2022
Q2 		$221K Buy
11,174
+163
+1% +$4.33K 0.05% 90
2022
Q1 		$348K Buy
11,011
+77
+0.7% +$2.16K 0.06% 86
2021
Q4 		$244K Buy
10,934
+99
+0.9% +$2.58K 0.04% 93
2021
Q3 		$301K Buy
10,835
+20
+0.2% +$609 0.04% 97
2021
Q2 		$421K Buy
10,815
+649
+6% +$23.3K 0.06% 82
2021
Q1 		$293K Buy
10,166
+5
+0% +$171 0.04% 93
2020
Q4 		$269K Hold
10,161
– – 0.04% 81
2020
Q3 		$155K Buy
+10,161
New +$213K 0.03% 89

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Gagnon Securities's CLB Position: Q2 2023 in Review

Gagnon Securities sold out of Core Laboratories (CLB) in Q2 2023, closing a stake of 11,283 shares — an estimated $249K sold.

Gagnon Securities first reported a position in CLB in Q3 2020 and held it in 11 quarters. The position peaked at $421K in Q2 2021. 164 funds tracked by Wall St. Rank hold CLB as of Q2 2023.

  • Gagnon Securities reported no remaining Core Laboratories position as of Q2 2023 after selling out during the quarter.
  • Gagnon Securities sold 11,283 Core Laboratories shares in Q2 2023, an estimated $249K.
  • Gagnon Securities first reported a position in Core Laboratories in Q3 2020 and held it in 11 quarters.
  • Gagnon Securities's Core Laboratories position peaked at $421K in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2023.

Based on Gagnon Securities's 13F filing for Q2 2023, filed 8 Aug 2023.